HomeREGULATORY
REGULATORY

MHLW Advisory Panel to Discuss Pediatric Dosages for Nexium on Nov. 2
(Oct.20.2017)

A key advisory committee of the Ministry of Health, Labor and Welfare (MHLW) will discuss on November 2 whether to recommend approval for pediatric dosages and a new formulation for AstraZeneca’s proton pump inhibitor Nexium (esomeprazole) ...
(LOG IN FOR FULL STORY)

News Calendar